Skip to Main Content

Paper Details

Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis.
Heart
17
2022
Author NameAffiliation
Irbaz Bin RiazMayo Clinic Arizona and Brigham and Women hospital, Harvard Medical School
Per Olav VandvikLovisenberg Diaconal Hospital
  • 1 - 2

Datasets

Release 1.2